Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML

Donor KIR and recipient HLA combinations that minimize inhibition and favor activation of the NK repertoire are associated with improved outcomes after allogeneic hematopoietic cell transplantation (HCT) in patients with myeloid neoplasia. We prospectively evaluated a weighted donor ranking algorith...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Shaffer, Brian C., Le Luduec, Jean-Benoit, Park, Soo, Devlin, Sean, Archer, Anne, Davis, Eric, Cooper, Candice, Nhaissi, Melissa, Suri, Beth, Wells, Deborah, Tamari, Roni, Papadopoulos, Esperanza, Jakubowski, Ann A., Giralt, Sergio, Hsu, Katharine C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2021
Gaiak:
Hematopoiesis and Stem Cells
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045509/
https://ncbi.nlm.nih.gov/pubmed/33843984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002701
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak